# Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)

> **NCT04545112** · NA · ENROLLING_BY_INVITATION · sponsor: **Xeltis** · enrollment: 20 (estimated)

## Conditions studied

- Multi Vessel Coronary Artery Disease

## Interventions

- **DEVICE:** CABG

## Key facts

- **NCT ID:** NCT04545112
- **Lead sponsor:** Xeltis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2020-10-22
- **Primary completion:** 2026-03-15
- **Final completion:** 2031-02-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04545112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04545112, "Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04545112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*